ArticleInvestigational new drugs2019
Dual targeting of bromodomain-containing 4 by AZD5153 and BCL2 by AZD4320 against B-cell lymphomas concomitantly overexpressing c-MYC and BCL2.
Tomoko Takimoto-Shimomura et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this papercites it